Quick10K

⚲

Gain Capital

Filings

10-Q	2020-03-31	Filed 2020-05-13
10-K	2019-12-31	Filed 2020-03-16
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-11
10-Q	2018-09-30	Filed 2018-11-06
10-Q	2018-06-30	Filed 2018-08-09
10-Q	2018-03-31	Filed 2018-05-09
10-K	2017-12-31	Filed 2018-03-14
10-Q	2017-09-30	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-08
10-Q	2017-03-31	Filed 2017-05-10
10-K	2016-12-31	Filed 2017-03-15
10-Q	2016-09-30	Filed 2016-11-08
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-09
10-K	2015-12-31	Filed 2016-03-17
10-Q	2015-09-30	Filed 2015-11-09
10-Q	2015-06-30	Filed 2015-08-10
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-16
10-Q	2014-09-30	Filed 2014-11-10
10-Q	2014-06-30	Filed 2014-08-11
10-Q	2014-03-31	Filed 2014-05-12
10-K	2013-12-31	Filed 2014-03-17
10-Q	2013-09-30	Filed 2013-11-12
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-03-18
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-09
10-Q	2012-03-31	Filed 2012-05-10
10-K	2011-12-31	Filed 2012-03-15
10-Q	2011-09-30	Filed 2011-11-10
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-05-16
10-K	2010-12-31	Filed 2011-03-30

Reports

8-K	2020-07-31
8-K	2020-07-23
8-K	2020-07-09
8-K	2020-06-09
8-K	2020-06-05
8-K	2020-05-22
8-K	2020-05-15
8-K	2020-05-14
8-K	2020-05-08
8-K	2020-05-08
8-K	2020-04-23
8-K	2020-04-10
8-K	2020-04-10
8-K	2020-03-09
8-K	2020-02-27
8-K	2020-02-27
8-K	2020-02-10
8-K	2020-01-13
8-K	2020-01-02
8-K	2019-12-10
8-K	2019-11-11
8-K	2019-10-25
8-K	2019-10-07
8-K	2019-10-07
8-K	2019-09-10
8-K	2019-08-15
8-K	2019-08-09
8-K	2019-08-08
8-K	2019-07-25
8-K	2019-07-18
8-K	2019-07-11
8-K	2019-07-09
8-K	2019-06-05
8-K	2019-06-05
8-K	2019-05-09
8-K	2019-04-25
8-K	2019-04-09
8-K	2019-04-08
8-K	2019-04-02
8-K	2019-03-11
8-K	2019-02-28
8-K	2019-02-08
8-K	2019-02-04
8-K	2019-01-08
8-K	2018-12-10
8-K	2018-11-28
8-K	2018-11-09
8-K	2018-10-25
8-K	2018-10-22
8-K	2018-10-04
8-K	2018-09-14
8-K	2018-09-11
8-K	2018-08-13
8-K	2018-07-26
8-K	2018-07-12
8-K	2018-07-09
8-K	2018-07-06
8-K	2018-06-08
8-K	2018-05-29
8-K	2018-05-09
8-K	2018-04-26
8-K	2018-04-06
8-K	2018-03-27
8-K	2018-03-12
8-K	2018-03-08
8-K	2018-02-08
8-K	2018-01-17
8-K	2018-01-10

Gain Capital Financials

GCAP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	346	371	371	351	427	446	457	477	684	739	806	840	850	760	827	1,109	986	921	876	1,061	1,055	945	1,042	947	960	979	1,203	1,281	1,250	1,017	993	968	985
Accounts Receivable										5	6	4	3	4	6	4	4	5	5	5	5	8	6	4	6	6	7	1	0	0
Inventory
PP&E	7	7	8	8	27	30	31	32	42	44	47	49	49	50	51	67	72	75	80	82	85	90	95	102	109	93	99	97	91	91	30	29	29
Assets	491	495	506	505	620	630	650	689	1,012	1,111	1,187	1,215	1,260	1,186	1,239	1,641	1,516	1,425	1,397	1,572	1,542	1,430	1,493	1,416	1,429	1,449	1,455	1,475	1,442	1,333	1,324	1,304	1,288
Accounts Payable
Long-Term Debt
Liabilities	325	324	341	341	450	466	487	510	789	877	940	970	997	911	957	1,295	1,173	1,108	1,078	1,255	1,236	1,129	1,214	1,120	1,136	1,158	1,147	1,119	1,083	1,035	1,055	1,041	1,035
Stockholders' Equity	166	171	165	164	170	164	164	179	223	234	239	237	252	265	272	333	332	306	307	304	293	294	273	291	289	286	306	353	357	298	269	263	253


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue																															35	72	63
Cost of Revenue																															58	59	57
Gross Profit																			32	28	3	37	-13	27	15	7	33	19	31		-23	13	6
R&D
SG&A	9	9	8	7	6	7	11	11	11	17	15	19	14	14	14	23	24	22	22	22	18	21	19	20	18	20	19	21	22		23	22	24
Tax	6	4	9	-1	1	-8	1	7	3	14	0	8	5	6	3	-4	0	-3	2	5	-3	6	0	4	0	-0	4	-0	4		6	2	-1
Net Income	10	8	-3	-1	3	-4	4	17	6	4	2	-5	16	18	9	-8	9	16	9	12	-4	21	-19	14	-2	-4	16	67	12	-2	-28	1	-2


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		32	9	-5		8	-32	52	-9	-29	10	-27	102	54	-37	54	59	2	34	-87	154	24	-35	19	36	-9	-2	14	-17		-23	-7	42
Cash Investing		-1	-2	-1		39	-1	-1	-6	-2	-10	-1	-24	-0	-1	-10	2	-7	-6	-6	-5	-14	-11	-6	-7	-4	-4	92	-6		-6	-4	-5
Cash Financing		-5	-5	-10		-2	8	-2	-13	40	-1	-1	-2	-2	-10	-2	-8	-6	-7	-4	-3	-7	-9	-7	-3	-3	-6	-6	-6		-6	-4	-2